PHOENIX BIOTECH ACQUISITION CORP.
Definitive Agreement
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $155M
- Underwriters
- Focus
- Healthcare, Life Sciences
- SEC Filings
- 1870404
- Public Embarc Page
- https://embarc.com/capital/spac/1870404/PBAX/phoenix-biotech-acquisition
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and DirectorChris Ehrlich
- Chief Financial OfficerDaniel Geffken
- PresidentDouglas Fisher
- DirectorBrian G. Atwood
- DirectorKathleen LaPorte
- DirectorBarbara Kosacz
- DirectorCaroline Loewy
Target Information
Information on the SPAC target for merger.
- Company
- CERo Therapeutics